Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Infection and Immunity
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Cellular Microbiology: Pathogen-Host Cell Molecular Interactions

The Type IVB Pili of Salmonella enterica Serovar Typhi Bind to the Cystic Fibrosis Transmembrane Conductance Regulator

Inez S. M. Tsui, Cecilia M. C. Yip, Jim Hackett, Christina Morris
Inez S. M. Tsui
Department of Biochemistry, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cecilia M. C. Yip
Department of Biochemistry, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jim Hackett
Department of Biochemistry, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina Morris
Department of Biochemistry, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bctina@ust.hk
DOI: 10.1128/IAI.71.10.6049-6050.2003
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Salmonella enterica serovar Typhi expresses type IVB pili. We show that the prePilS protein (the soluble precursor form of the structural pilin) interacts with a 15-mer peptide representing the first extracellular domain of the cystic fibrosis transmembrane conductance regulator (CFTR), a recognized human epithelial cell receptor for serovar Typhi (G. B. Pier et al., Nature 393:79-82, 1998). This indicates that after mediating bacterial self-association (C. Morris et al., Infect. Immun. 71:1141-1146, 2003), the pili then act to attach the bacterial clumps to CFTR in the membrane of gut epithelial cells. These sequential type IVB pilus-mediated events cannot be performed by (for example) S. enterica serovar Typhimurium, which may explain why only serovar Typhi causes epidemics of enteric fever in humans.

The type IVB pilus operon of Salmonella enterica serovar Typhi contains a pilS gene encoding the structural pilin (1, 5). A pilS mutant of serovar Typhi was much reduced in adhesion to and invasion of human epithelial gastrointestinal cells in vitro, and soluble purified prePilS protein (retaining the signal sequence normally cleaved when the protein is excreted to form insoluble pili based on polymerized PilS) inhibited bacterial invasion (5). While the pili mediate bacterial self-association (3), these data did not explain why purified prepilin should inhibit serovar Typhi entry to human intestinal epithelial cells. This rather suggested that the prepilin might interact with an epithelial cell receptor.

It is known that the first extracellular domain of the cystic fibrosis transmembrane conductance regulator (CFTR) is a serovar Typhi receptor domain (4). To determine if soluble prePilS protein could interact with this domain of CFTR, bacteria of serovar Typhi strain J341 (Ty2 Vi−) (5), grown in Luria broth for 14 to 16 h at 30°C to reach optical densities at 600 nm of 0.5 to 0.7, were resuspended in Eagle's basal medium, which also contained CFTR peptides, prePilS protein, or both. Then the bacteria were centrifuged for 10 min at 3,500 × g onto washed cells (bacterium/cell ratio of 1:1) of the human embryonic intestine cell line INT407 (4). Bacterium-cell interaction proceeded for 2 h at 37°C in a 5% (vol/vol) CO2 atmosphere. After incubation, cells were washed, treated with gentamicin, washed once more, and lysed for enumeration of internalized bacteria (3 to 5% of added bacteria, in the absence of an inhibitor of INT407 cell entry by serovar Typhi) (5).

The 15-mer peptides representing the first extracellular human CFTR domain (GRIIASYDPDNKEER) and a scrambled version of this domain (GKDPNYRDEAIRSIE) (4) were synthesized by Research Genetics, Huntsville, Ala.. The prePilS protein was purified from a glutathione S-transferase (GST) fusion protein, expressed in Escherichia coli K-12 as previously described (5). Affinity beads with bound fusion protein were washed with 100 volumes of phosphate-buffered saline (PBS) before thrombin cleavage of prePilS, and the prePilS preparation was confirmed to be free of bacterial lipopolysaccharide in assays detecting periodate-cleavable carbohydrate. Also, heat (boiling for 5 min) destroyed the ability of prePilS to inhibit eukaryotic cell entry by serovar Typhi, in that boiled prePilS at 4 μM did not detectably inhibit such entry, while ca. 75% cell entry inhibition was afforded by the same concentration of native prePilS (described below).

As demonstrated before (5), prePilS protein inhibited serovar Typhi entry into INT407 cells, with 50% inhibition noted at ca. 2 μM prePilS (Fig. 1A). Addition of the scrambled version of the CFTR 15-mer to assays including prePilS protein did not affect the inhibition noted. When the authentic CFTR 15-mer was present (at 2 μM) in assays in which the prePilS protein was included at 1, 2, 3, or 4 μM, the CFTR 15-mer effectively neutralized the INT407 cell entry inhibition afforded by prePilS protein (Fig. 1A). In the reciprocal experiment (Fig. 1B), the CFTR 15-mer inhibited INT407 cell entry by serovar Typhi, as expected (4), while the scrambled version of the CFTR 15-mer was without inhibitory effect (data not shown). When prePilS protein was present at 2 μM in assays in which the CFTR 15-mer was included at 1, 2, 3, or 4 μM, prePilS protein effectively neutralized the INT407 cell entry inhibition caused by the CFTR 15-mer (Fig. 1B). Maximal INT407 cell entry (ca. 75%) was seen when the 15-mer and prePilS were in equimolar proportions; an excess of either component reduced INT407 cell entry from this peak. A two-way analysis of variance with INT407 cell entry level as the dependent variable and concentrations of prePilS and CFTR 15-mer as independent variables showed that the prePilS-CFTR peptide interactions of both Fig. 1A and B were significant, with P < 0.001.

These data indicate that the prePilS protein and the CFTR 15-mer interact, and this in turn suggests that the PilS protein of the type IVB pili binds to CFTR in the INT407 cell membrane. It was not possible to use purified PilS protein in the tests described above, because PilS is insoluble, precipitating in the affinity matrix upon thrombin release from a GST conjugate (data not shown). Because the signal sequence of prePilS will be removed upon PilS secretion by serovar Typhi, a physiologically relevant interaction with CFTR would involve the PilS portion of prePilS.

Serovar Typhi bacteria use the type IVB pili for bacterial self-association (3). The data described here suggest that such aggregates may use the pili also to bind to the human intestinal cell membrane. The next step would logically be bacterial invasion of the intestinal mucosa, perhaps facilitated by association of bacterial lipopolysaccharide to pili-recruited CFTR (2). Because expression of the type IVB pili is confined to serovar Typhi and a few human-invasive strains of S. enterica serovars Paratyphi C and Dublin (our unpublished observations), expression of the type IVB pili may be important in the mediation of enteric fever in humans.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

Effects of CFTR peptides and prePilS protein on INT407 cell entry by S. enterica serovar Typhi. Cell entry levels of serovar Typhi in the absence of any added CFTR peptides or prePilS protein were set at 100%. Each point represents the mean of seven tests, each run in quintuplicate; standard error bars are shown. s15-mer, scrambled CFTR 15-mer.

ACKNOWLEDGMENTS

This work was supported by the Hong Kong Government Research Grants Council.

FOOTNOTES

    • Received 6 January 2003.
    • Returned for modification 10 April 2003.
    • Accepted 14 July 2003.
  • Copyright © 2003 American Society for Microbiology

REFERENCES

  1. 1.↵
    Kim, S.-R., and T. Komano. 1997. The plasmid R64 thin pilus identified as a type IV pilus. J. Bacteriol.179:3594-3603.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Lyczak, J. B., and G. B. Pier. 2002. Salmonella enterica serovar Typhi modulates cell surface expression of its receptor, the cystic fibrosis transmembrane conductance regulator, on the intestinal epithelium. Infect. Immun.70:6416-6423.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    Morris, C., C. M. C. Yip, I. S. M. Tsui, D. K.-H. Wong, and J. Hackett. 2003. The shufflon of Salmonella enterica serovar Typhi regulates type IVB pilus-mediated bacterial self-association. Infect. Immun.71:1141-1146.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Pier, G. B., M. Grout, T. Zaidi, G. Meluleni, S. S. Mueschenborn, G. Banting, R. Ratcliff, M. J. Evans, and W. H. Colledge. 1998. Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature393:79-82.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    Zhang, X.-L., I. S. M. Tsui, C. M. C. Yip, A. W. Y. Fung, D. K.-H. Wong, X. Dai, Y. Yang, J. Hackett, and C. Morris. 2000. Salmonella typhi uses type IVB pili to enter human intestinal epithelial cells. Infect. Immun.68:3067-3073.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Download PDF
Citation Tools
The Type IVB Pili of Salmonella enterica Serovar Typhi Bind to the Cystic Fibrosis Transmembrane Conductance Regulator
Inez S. M. Tsui, Cecilia M. C. Yip, Jim Hackett, Christina Morris
Infection and Immunity Sep 2003, 71 (10) 6049-6050; DOI: 10.1128/IAI.71.10.6049-6050.2003

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Infection and Immunity article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Type IVB Pili of Salmonella enterica Serovar Typhi Bind to the Cystic Fibrosis Transmembrane Conductance Regulator
(Your Name) has forwarded a page to you from Infection and Immunity
(Your Name) thought you would be interested in this article in Infection and Immunity.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The Type IVB Pili of Salmonella enterica Serovar Typhi Bind to the Cystic Fibrosis Transmembrane Conductance Regulator
Inez S. M. Tsui, Cecilia M. C. Yip, Jim Hackett, Christina Morris
Infection and Immunity Sep 2003, 71 (10) 6049-6050; DOI: 10.1128/IAI.71.10.6049-6050.2003
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Cystic Fibrosis Transmembrane Conductance Regulator
Fimbriae Proteins
Fimbriae, Bacterial
Salmonella typhi

Related Articles

Cited By...

About

  • About IAI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #IAIjournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0019-9567; Online ISSN: 1098-5522